Solasto Corporation

6197.T
Medical Care Facilities
2026/04/09 Updated
Market Cap: $635.6M (¥101.2B)
Stock Price: $7.01 (¥1,116)
Exchange Rate: 1 USD = ¥159.24

(Correction) Notice Regarding the Correction to the Tender Offer Commencement Announcement Following the Submission of a Correction to the Tender Offer Notification by MP-2605 Corporation

MP-2605 Corporation submitted a partial correction to its tender offer notification for ordinary shares of Solasto Corporation, starting March 25, 2026, to the Kanto Finance Bureau Director on April 9, 2026, and amended the contents of the tender offer commencement announcement accordingly.

Importance:
Page Updated: April 9, 2026
IR Disclosure Date: April 9, 2026

Key Figures

  • Tender Offer Commencement Date: 2026年3月25日
  • Tender Offer Notification Correction Date: 2026年4月9日
  • Book Value Equivalent to 10% of Net Assets: 1,654 million yen

AI要約

Regarding the Correction to the Tender Offer Notification

MP-2605 Corporation submitted a correction to the tender offer notification dated March 25, 2026, concerning the ordinary shares of Solasto Corporation, to the Kanto Finance Bureau Director on April 9, 2026, in accordance with the Financial Instruments and Exchange Act. Consequently, the content of the tender offer commencement announcement has also been partially amended. The primary correction pertains to revisions of clauses related to conditions for withdrawal of the tender offer and other terms, and does not involve changes to the tender offer conditions.

Tender Offer Overview and Important Notices

This tender offer aims to acquire all ordinary shares of Solasto Corporation, excluding treasury shares and specified shares, with the objective of taking the company private. Following the shortening of the waiting period based on the Foreign Exchange and Foreign Trade Act, share acquisition became possible from April 8, 2026. This document does not constitute a solicitation for sale, and applicants are advised to carefully review the tender offer memorandum before applying. Additionally, it is noted that the procedures differ from U.S. securities laws.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.